Physicians Realty Trust Earnings Recaps
Q2 2026
Aug 7, 2026
Shares declined 2.4% following the report, reflecting investor caution despite solid leasing in outpatient medical and growth in senior housing, likely due to margin pressures and a tempered outlook on near-term growth acceleration.
Key takeaways
- FFO as adjusted came in at $0.46 per share with net debt-to-EBITDA of 4.7x, indicating a stable but leveraged balance sheet.
- Outpatient medical leasing remained strong with 1.2 million square feet executed in Q2, including 327,000 square feet of new leases, continuing positive momentum.
- Senior housing same-store occupancy increased by 260 basis points while NOI grew 19%, driven by Janus Living’s accelerating footprint and unique deal structure.
- The company completed a $1 billion strategic partnership with Brookfield on outpatient medical assets, providing capital recycling and expanding alternative equity capital sources.
- Management highlighted cautious capital allocation and patience on acquisitions or buybacks given current market conditions and the cost of debt relative to cap rates.
Q1 2026
May 7, 2026
Shares rallied 19.1% following a standout quarter marked by an accretive IPO of the senior housing business, ongoing leasing momentum in outpatient medical properties, and an upgraded 2026 earnings outlook supported by strategic capital recycling and buybacks.
Key takeaways
- Completed the Janus Living senior housing IPO, monetizing an 18% stake while maintaining exposure; current FFO from Janus portfolio valued at a ~20x multiple compared to Healthpeak’s.
- Executed $700M+ acquisitions ahead of IPO to capture significant multiple arbitrage; IPO proceeds expected to add approximately $0.04 per share in earnings once fully invested and stabilized.
- Outpatient Medical segment signed 1.1 million square feet of leases, achieving 5.4–5.8% cash re-leasing spreads, 79% tenant retention, and 91% total occupancy.
- Raised $170 million via joint venture recapitalization with Blackstone at 6.1% cap rate, with plans for additional $700 million+ transactions at cap rates significantly above implied stock valuation.
- Bought back $100 million of stock at >10% FFO yield, boosting 2026 guidance, while maintaining a 7.5% annualized dividend yield on a solid payout ratio.
Q3 2025
Oct 24, 2025
Healthpeak Properties reported strong Q3 2025 performance, driven by strategic portfolio enhancements and positive indicators in the life science market. Strong NOI growth and robust leasing activity signal a potential turnaround in the sector.
Key takeaways
- FFO as adjusted was $0.46 per share, with an AFFO of $0.42 per share, reflecting consistent financial performance.
- Solid growth in the CCRC portfolio led to a 9.4% increase in cash NOI for the quarter, with significant year-over-year occupancy gains.
- The merger with Physicians Realty Trust adds $5 billion in value and enhances operational efficiencies through internalized property management.
- A strategic focus on outpatient medical assets positions the company to capitalize on improving market conditions with potential asset sales exceeding $1 billion.
- Technology initiatives are set to enhance operational efficiency and support innovative property management, aiming for long-term competitive advantages.